Evidence map›Paper›PMID 27794468›Full record

ReviewInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2017

Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade.

Danielle Cazabon, Hannah Alsdurf, Srinath Satyanarayana, Ruvandhi Nathavitharana, Ramnath Subbaraman, Amrita Daftary, Madhukar Pai

Abstract readReview
In one paragraph

Review in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tuberculosis: An Update for the Clinician.Respirology (Carlton, Vic.) · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Danielle CazabonMcGill International TB Centre, McGill University, 1020 Pine Ave West, Montreal, QC H3A 1A2, Canada.
Hannah AlsdurfMcGill International TB Centre, McGill University, 1020 Pine Ave West, Montreal, QC H3A 1A2, Canada.
Srinath SatyanarayanaMcGill International TB Centre, McGill University, 1020 Pine Ave West, Montreal, QC H3A 1A2, Canada.
Ruvandhi NathavitharanaDivision of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Ramnath SubbaramanDivision of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Amrita DaftaryMcGill International TB Centre, McGill University, 1020 Pine Ave West, Montreal, QC H3A 1A2, Canada; CAPRISA MRC HIV-TB Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal, South Africa.
Madhukar PaiMcGill International TB Centre, McGill University, 1020 Pine Ave West, Montreal, QC H3A 1A2, Canada; Manipal McGill Centre for Infectious Diseases, Manipal University, Manipal, India. Electronic address: madhukar.pai@mcgill.ca.

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
Harvard Clinical and Translational Science CenterKL2TR001100 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$8.5M
Global Health Fellows and Scholars Research TrainingR25TW009338 · FIC · UNIVERSITY OF CALIFORNIA BERKELEY · PI BARRY, MICHELE, KO, ALBERT ICKSANG · 2012 to 2016
$5.2M
FIC NIH HHS D43 TW010540FIC NIH HHS R25 TW009338NCATS NIH HHS KL2 TR001100NIAID NIH HHS P30 AI060354
6 · The paper itself

Abstract

Despite the high coverage of directly observed treatment short-course (DOTS), tuberculosis (TB) continues to affect 10.4 million people each year, and kills 1.8 million. High TB mortality, the large number of missing TB cases, the emergence of severe forms of drug resistance, and the slow decline in TB incidence indicate that merely expanding the coverage of TB services is insufficient to end the epidemic. In the era of the End TB Strategy, we need to think beyond coverage and start focusing on the quality of TB care that is routinely offered to patients in high burden countries, in both public and private sectors. In this review, current evidence on the quality of TB care in high burden countries, major gaps in the quality of care, and some novel efforts to measure and improve the quality of care are described. Based on systematic reviews on the quality of TB care or surrogates of quality (e.g., TB diagnostic delays), analyses of TB care cascades, and newer studies that directly measure quality of care, it is shown that the quality of care in both the public and private sector falls short of international standards and urgently needs improvement. National TB programs will therefore need to systematically measure and improve quality of TB care and invest in quality improvement programs.

Indexed as

Health Services Needs and DemandQuality ImprovementQuality of Health CareHealth PolicyHumansPatient-Centered CarePrivate SectorProgram DevelopmentPublic SectorTuberculosisTuberculosis, Multidrug-ResistantCascade of careQuality improvementQuality of careStandards for TB careTuberculosis

Identifiers

PMID27794468
PMCPMC5346036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.